Sharemaestro Newsreel

XWEL Q3 2023 Earnings: EPS Misses by 191.67% as Shares Slide 10% - Financial Summary

Myriad Genetics (MYGN) Stock Sinks As Revenue Reset Deepens Loss Fears

Myriad Genetics (MYGN) stock sharply declined by nearly 47% after reporting a Q2 revenue reset and cutting full-year sales guidance, deepening fears of prolonged losses. Despite some clinical advancements in its oncology portfolio, the company experienced weakened average revenue per test and reduced gross …

Castle Biosciences 2026: Revenue $103.55M, EPS ($0.07) — 10-Q Summary

Castle Biosciences (CSTL) reported its 2026 financial results, showing revenue of $103.55 million, an increase from $86.19 million in the previous year. However, the company posted a net loss of ($2.06 million) and diluted EPS of ($0.07), a decline from the prior year's net …

Castle Biosciences, Inc. Stock 12‑Month Price Target Raised to $43.56, Implies 63% Upside

Castle Biosciences, Inc. (CSTL) has seen its average 12-month price target raised to $43.56 from $42.78 by 9 analysts, implying a potential upside of approximately 63% from its July 30 closing price. The consensus rating for the stock remains a "Buy" across all covering …

Waters Corporation Bonds — Corporate Bond Rates

This article provides a list of Waters Corporation bonds, sorted by yield to worst, noting that investors often choose bonds for their stability during market volatility. It includes detailed financial data for various Augusta SpinCo Corp bonds, such as yield to worst, price, coupon …

WGS Deadline: WGS Investors with Losses in Excess of $100K Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

The Rosen Law Firm is reminding investors who purchased common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025, and May 4, 2026, of the August 3, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that GeneDx made …

bioAffinity Technologies Faces Nasdaq Delisting Risk After Notice

bioAffinity Technologies (BIAF) has received a delisting notice from Nasdaq because its stock failed to maintain the minimum $1.00 bid price for 30 consecutive business days. The company is ineligible for the standard compliance period due to a reverse stock split in the previous …

MDxHealth SA (0O8G.L) stock price, news, quote and history

This page on Yahoo Finance provides the stock price, news, quote, and historical data for MDxHealth SA (0O8G.L). As of December 15th, the stock was trading at 3.0198 EUR, down 5.64% for the day. The page also features trending tickers and market indices.

Twist Bioscience Reports Monday With Breakeven Timeline Now Three Quarters Away

Twist Bioscience (TWST) is set to report fiscal third-quarter earnings, with investors focusing on the company's path to profitability and its role in AI-enabled drug discovery after a significant 154% surge in its stock price over the past year. Analysts have a largely bullish …

PMN|ProMIS Neurosciences Inc|Price:13.720|Chg%:-1.200

This article provides a comprehensive stock analysis of ProMIS Neurosciences Inc (PMN), highlighting its strong fundamentals and high growth potential. The company's valuation is considered fair, and institutional ownership is notably high. Analysts have issued "Buy" ratings, projecting a significant upside for the stock …

OPKO Health (OPK) Is Up 14.1% After Narrower Q2 Loss and New 2026 Revenue Guidance – Has The Bull Case Changed?

OPKO Health (OPK) reported a significantly narrower Q2 net loss of US$8.42 million and issued new 2026 revenue guidance of US$560 million to US$585 million, leading to a 14.1% stock increase. The article explores whether this reduced loss and updated guidance change the investment …

Danaher Stock vs XHB ETF: Complete Performance Comparison

This article compares Danaher (DHR) stock, a life sciences and diagnostics company, with the XHB ETF, which tracks homebuilding companies, across returns, risk, and dividends. It highlights Danaher's strong fundamentals and dividend record against XHB's exposure to the volatile housing market, guiding investors to …

Adaptive Biotechnologies Corporation Revenue Breakdown – NASDAQ:ADPT

How Investors May Respond To Tempus AI (TEM) Q2 Profit Return, Outlook Hike, Personalis Deal

Tempus AI (TEM) reported a profitable Q2 2026, swinging from a net loss to a net income of US$5.64 million, with revenue of US$382.49 million, and subsequently raised its full-year 2026 revenue outlook. The company also announced the acquisition of Personalis, enhancing its oncology …

ICON plc (NASDAQ: ICLR) investors pass all AGM resolutions and back directors

ICON plc announced that all resolutions presented at its Annual General Meeting on July 31, 2026, were duly passed by shareholders. These approvals include the re-election of existing directors, the election of new directors, and significant share capital authorities such as the ability to …

Quantinno Capital Management LP Has $27.38 Million Stake in Mettler-Toledo International, Inc. $MTD

Quantinno Capital Management LP significantly increased its stake in Mettler-Toledo International, Inc. by 12.3% in the first quarter of 2026, bringing its total holding to 21,708 shares valued at $27.38 million. This comes as Mettler-Toledo reported strong quarterly earnings, beating expectations with adjusted EPS …

Guardant Health Earnings: Shield Momentum Shows No Signs Of Slowing, Guidance Raised Again

Guardant Health reported strong second-quarter results, with 44% revenue growth and a 50% sequential increase in Shield colorectal cancer screening tests. Following this performance, management raised its full-year revenue guidance to $1.35 billion at the midpoint, marking a 3% increase from previous guidance. This …

California State Teachers Retirement System Reduces Position in Mettler-Toledo International, Inc. $MTD

The California State Teachers Retirement System recently reduced its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 2.5% in the first quarter, selling 794 shares. Despite this, other institutional investors have either increased their positions or initiated new ones in the medical instruments supplier. The …

Mettler-Toledo International, Inc. $MTD Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company has reduced its stake in Mettler-Toledo International, Inc. (MTD) by 4.2%, selling 937 shares but still retaining 21,571 shares valued at approximately $27.2 million. This comes as Mettler-Toledo exceeded quarterly earnings expectations with an adjusted EPS of $11.46 and …

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH) and Cytokinetics (CYTK)

This article highlights bullish analyst sentiments for two healthcare companies: Labcorp Holdings (LH) and Cytokinetics (CYTK). William Blair analyst Jared Haase maintained a Buy rating on Labcorp Holdings with a $313.43 average price target, while H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating …

CSTL (CSTL) insider schedules potential $630,000 sale of 22,500 shares

An affiliate of CASTLE BIOSCIENCES INC (CSTL) has filed a Form 144 to sell 22,500 shares of common stock, with an aggregate market value of $630,000. The shares, originating from various equity compensation grants including Restricted Stock Units and Restricted Stock Awards, are scheduled …

ETFs Investing in IDEXX Laboratories, Inc. Stocks

This article lists various ETFs that include IDEXX Laboratories, Inc. (IDXX) stocks in their holdings. It provides detailed financial information for each ETF, such as market value, weight of IDXX, issuer, management style, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV …

Summitry LLC Raises Holdings in Agilent Technologies, Inc. $A

Summitry LLC increased its stake in Agilent Technologies (NYSE:A) by 8.1% in the first quarter, now owning 673,954 shares valued at approximately $76.8 million. Agilent Technologies reported strong quarterly earnings, beating consensus estimates with $1.49 EPS and $1.83 billion in revenue, while maintaining its …

bioAffinity Technologies Received Notice of Delisting

bioAffinity Technologies (BIAF) has received a delisting notice from Nasdaq because its stock failed to maintain the minimum $1.00 bid price for 30 consecutive business days. The company is ineligible for the standard compliance period due to a reverse stock split in the previous …

Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Consensus Recommendation of "Hold" from Analysts

Analysts have issued a "Hold" consensus recommendation for Fulgent Genetics (NASDAQ:FLGT), with an average 12-month price target of $27.00. The company recently reported Q2 2026 revenue of $85.4 million, missing estimates, and a non-GAAP loss of $0.58 per share, which exceeded expectations. Management also …

SMMT|Summit Therapeutics Inc|Price:13.030|Chg%:-0.410

This article provides a comprehensive stock analysis of Summit Therapeutics Inc (SMMT) from TradingKey. It highlights the company's healthy fundamentals, high growth potential, and fairly valued stock, despite recent weak market performance. The analysis also details analyst ratings, institutional ownership, and key strengths like …

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC (KSF) has reminded investors of GeneDx Holdings Corp. (NASDAQ: WGS) with substantial losses that they have until August 3, 2026, to file lead plaintiff applications in a securities class action lawsuit. The lawsuit alleges that GeneDx and its executives …

Check-Cap Ltd. Revenue Breakdown – NASDAQ:MBAI

Price to book forward of Check-Cap Ltd. – NASDAQ:MBAI

This page from TradingView provides financial information for Check-Cap Ltd. (NASDAQ: MBAI), specifically focusing on its forward price-to-book ratio. It is a financial data point presented without additional commentary or analysis. The article itself is a stub page for financial data rather than a …

Adaptive Biotechnologies Corp (ADPT) Shares Fall 6.7% -- GF Value Says Still Overvalued

Adaptive Biotechnologies Corp (ADPT) shares dropped 6.7%, and GuruFocus's GF Value suggests the stock is 125.0% overvalued at $22.57 compared to its estimated fair value of $10.03. Despite an above-average GF Score of 66/100, driven by strong growth and momentum ranks, its financial strength …

XNCR|Xencor Inc|Price:20.220|Chg%:-1.270

This article provides a comprehensive stock analysis of Xencor Inc (XNCR), highlighting its stable fundamentals, significant growth potential, and "fairly valued" status. It notes high institutional ownership and multiple analyst "Buy" ratings with a target price of $29.64. The company, a clinical-stage biopharmaceutical firm, …

Veracyte (VCYT) Stock Sinks As Profit Strength Meets Reimbursement Doubt

Mettler Toledo (MTD) Stock Jumps On EPS Beat As Valuation Debate Deepens

Key facts: CareDx (CDNA) raises 2026 revenue guide; grants 15,822 RSUs

Qiagen (QGEN) Stock Could Be A Cash Flow Bargain Yet Fair On Earnings

GeneDx Holdings Corp. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

Kahn Swick & Foti, LLC (KSF) is reminding investors in GeneDx Holdings Corp. (NasdaqGS: WGS) that they have until August 3, 2026, to apply for lead plaintiff in a securities class action lawsuit. The lawsuit alleges that GeneDx and its executives made false and …